EphrinB3 blocks EphB3 dependence receptor functions to prevent cell death following traumatic brain injury

Cell Death and Disease

Volumn 5, Issue 5, 2014, Pages

  Theus, M H ^a   Ricard, J ^b   Glass, S J ^b   Travieso, L G ^b   Liebl, D J ^b  

^a VIRGINIA MARYLAND REGIONAL COLLEGE OF VETERINARY MEDICINE   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Controlled cortical impact (CCI) injury; Eph receptors; Ephrins; Traumatic brain injury (TBI)

Indexed keywords

CASPASE; DNA NUCLEOTIDYLEXOTRANSFERASE; EPHRIN B3; MICROTUBULE ASSOCIATED PROTEIN 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN FUNCTION; CELL DEATH; CELL SURVIVAL; CONTROLLED STUDY; DENTATE GYRUS; FOREBRAIN; HIPPOCAMPAL CA3 REGION; MALE; MOTOR PERFORMANCE; MOUSE; NERVE CELL; NERVOUS SYSTEM DEVELOPMENT; NEUROPROTECTION; NICK END LABELING; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN CLEAVAGE; SUBVENTRICULAR ZONE; TRAUMATIC BRAIN INJURY; WILD TYPE;

ANIMALS; APOPTOSIS; BRAIN; BRAIN INJURIES; CELL LINE, TUMOR; CYTOPROTECTION; DISEASE MODELS, ANIMAL; EPHRIN-B3; HEK293 CELLS; HUMANS; INFUSIONS, INTRAVENTRICULAR; MALE; MICE; MICE, KNOCKOUT; MOTOR ACTIVITY; NERVE DEGENERATION; NEURONS; NEUROPROTECTIVE AGENTS; RECEPTOR, EPHB3; RECOVERY OF FUNCTION; ROTAROD PERFORMANCE TEST; TIME FACTORS; TRANSFECTION;

EID: 84901008799     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2014.165     Document Type: Article

References (46)

1. Awasthi D, Church DF, Torbati D, Carey ME, Pryor WA. Oxidative stress following traumatic brain injury in rats. Surg Neurol 1997; 47: 575-581.
2. Chen S, Pickard JD, Harris NG. Time course of cellular pathology after controlled cortical impact injury. Exp Neurol 2003; 182: 87-102.
3. Beer R, Franz G, Srinivasan A, Hayes RL, Pike BR, Newcomb JK et al. Temporal profile and cell subtype distribution of activated caspase-3 following experimental traumatic brain injury. J Neurochem 2000; 75: 1264-1273.
4. Sutton RL, Lescaudron L, Stein DG. Unilateral cortical contusion injury in the rat: vascular disruption and temporal development of cortical necrosis. J Neurotrauma 1993; 10: 135-149.
5. Kumar R, Husain M, Gupta RK, Hasan KM, Haris M, Agarwal AK et al. Serial changes in the white matter diffusion tensor imaging metrics in moderate traumatic brain injury and correlation with neuro-cognitive function. J Neurotrauma 2009; 26: 481-495.
6. Bramlett HM, Dietrich WD. Progressive damage after brain and spinal cord injury: pathomechanisms and treatment strategies. Prog Brain Res 2007; 161: 125-141.
7. Klein M, Houx PJ, Jolles J. Long-term persisting cognitive sequelae of traumatic brain injury and the effect of age. J Nerv Ment Dis 1996; 184: 459-467.
8. Hamm RJ, Dixon CE, Gbadebo DM, Singha AK, Jenkins LW, Lyeth BG et al. Cognitive deficits following traumatic brain injury produced by controlled cortical impact. J Neurotrauma 1992; 9: 11-20.
9. Hamm RJ, Pike BR, O'Dell DM, Lyeth BG, Jenkins LW. The rotarod test: an evaluation of its effectiveness in assessing motor deficits following traumatic brain injury. J Neurotrauma 1994; 11: 187-196.
10. McIntosh TK, Vink R, Noble L, Yamakami I, Fernyak S, Soares H et al. Traumatic brain injury in the rat: characterization of a lateral fluid-percussion model. Neuroscience 1989; 28: 233-244.
11. Gorio A, Gokmen N, Erbayraktar S, Yilmaz O, Madaschi L, Cichetti C et al. Recombinant human erythropoietin counteracts secondary injury and markedly enhances neurological recovery from experimental spinal cord trauma. Proc Natl Acad Sci USA 2002; 99: 9450-9455.
12. Kang JQ, Chong ZZ, Maiese K. Critical role for Akt1 in the modulation of apoptotic phosphatidylserine exposure and microglial activation. Mol Pharmacol 2003; 64: 557-569.
13. Sakanaka M, Wen TC, Matsuda S, Masuda S, Morishita E, Nagao M et al. In vivo evidence that erythropoietin protects neurons from ischemic damage. Proc Natl Acad Sci USA 1998; 95: 4635-4640.
14. Knoblach SM, Alroy DA, Nikolaeva M, Cernak I, Stoica BA, Faden AI. Caspase inhibitor z-DEVD-fmk attenuates calpain and necrotic cell death in vitro and after traumatic brain injury. J Cereb Blood Flow Metab 2004; 24: 1119-1132.
15. Howard MA, Rodenas-Ruano A, Henkemeyer M, Martin GK, Lonsbury-Martin BL, Liebl DJ. Eph receptor deficiencies lead to altered cochlear function. Hear Res 2003; 178: 118-130.
16. Liebl DJ, Morris CJ, Henkemeyer M, Parada LF. mRNA expression of ephrins and Eph receptor tyrosine kinases in the neonatal and adult mouse central nervous system. J Neurosci Res 2003; 71: 7-22.
17. Mendes SW, Henkemeyer M, Liebl DJ. Multiple Eph receptors and B-class ephrins regulate midline crossing of corpus callosum fibers in the developing mouse forebrain. J Neurosci 2006; 26: 882-892.
18. Rodenas-Ruano A, Perez-Pinzon MA, Green EJ, Henkemeyer M, Liebl DJ. Distinct roles for ephrinB3 in the formation and function of hippocampal synapses. Dev Biol 2006; 292: 34-45.
19. Goldshmit Y, McLenachan S, Turnley A. Roles of Eph receptors and ephrins in the normal and damaged adult CNS. Brain Res Rev 2006; 52: 327-345.
20. Pasquale EB. Eph receptor signalling casts a wide net on cell behaviour. Nat Rev Mol Cell Biol 2005; 6: 462-475.
21. Cruz-Orengo L, Figueroa JD, Velazquez I, Torrado A, Ortiz C, Hernandez C et al. Blocking EphA4 upregulation after spinal cord injury results in enhanced chronic pain. Exp Neurol 2006; 202: 421-433.
22. Figueroa JD, Benton RL, Velazquez I, Torrado AI, Ortiz CM, Hernandez CM et al. Inhibition of EphA7 up-regulation after spinal cord injury reduces apoptosis and promotes locomotor recovery. J Neurosci Res 2006; 84: 1438-1451.
23. Miranda JD, White LA, Marcillo AE, Willson CA, Jagid J, Whittemore SR. Induction of Eph B3 after spinal cord injury. Exp Neurol 1999; 156: 218-222.
24. Willson CA, Irizarry-Ramirez M, Gaskins HE, Cruz-Orengo L, Figueroa JD, Whittemore SR et al. Upregulation of EphA receptor expression in the injured adult rat spinal cord. Cell Transplant 2002; 11: 229-239.
25. Willson CA, Miranda JD, Foster RD, Onifer SM, Whittemore SR. Transection of the adult rat spinal cord upregulates EphB3 receptor and ligand expression. Cell Transplant 2003; 12: 279-290.
26. Omoto S, Ueno M, Mochio S, Yamashita T. Corticospinal tract fibers cross the ephrin-B3- negative part of the midline of the spinal cord after brain injury. Neurosci Res 2011; 69: 187-195.
27. Goldshmit Y, Galea MP, Wise G, Bartlett PF, Turnley AM. Axonal regeneration and lack of astrocytic gliosis in EphA4-deficient mice. J Neurosci 2004; 24: 10064-10073.
28. Sobel RA. Ephrin A receptors and ligands in lesions and normal-appearing white matter in multiple sclerosis. Brain Pathol 2005; 15: 35-45.
29. Furne C, Ricard J, Cabrera JR, Pays L, Bethea JR, Mehlen P et al. EphrinB3 is an anti-apoptotic ligand that inhibits the dependence receptor functions of EphA4 receptors during adult neurogenesis. Biochim Biophys Acta 2009; 1793: 231-238.
30. Theus MH, Ricard J, Bethea JR, Liebl DJ. EphB3 limits the expansion of neural progenitor cells in the subventricular zone by regulating p53 during homeostasis and following traumatic brain injury. Stem Cells 2010; 28: 1231-1242.
31. Zhuang Z, Yang B, Theus MH, Sick JT, Bethea JR, Sick TJ et al. EphrinBs regulate D-serine synthesis and release in astrocytes. J Neurosci 2010; 30: 16015-16024.
32. Duffy P, Wang X, Siegel CS, Tu N, Henkemeyer M, Cafferty WB et al. Myelin-derived ephrinB3 restricts axonal regeneration and recovery after adult CNS injury. Proc Natl Acad Sci USA 2012; 109: 5063-5068.
33. Mehlen P, Bredesen DE. The dependence receptor hypothesis. Apoptosis 2004; 9: 37-49.
34. Mehlen P, Rabizadeh S, Snipas SJ, Assa-Munt N, Salvesen GS, Bredesen DE. The DCC gene product induces apoptosis by a mechanism requiring receptor proteolysis. Nature 1998; 395: 801-804.
35. Mehlen P, Thibert C. Dependence receptors: between life and death. Cell Mol Life Sci 2004; 61: 1854-1866.
36. Tauszig-Delamasure S, Yu LY, Cabrera JR, Bouzas-Rodriguez J, Mermet-Bouvier C, Guix C et al. The TrkC receptor induces apoptosis when the dependence receptor notion meets the neurotrophin paradigm. Proc Natl Acad Sci USA 2007; 104: 13361-13366.
37. Tulasne D, Deheuninck J, Lourenco FC, Lamballe F, Ji Z, Leroy C et al. Proapoptotic function of the MET tyrosine kinase receptor through caspase cleavage. Mol Cell Biol 2004; 24: 10328-10339.
38. del Rio G, Kane DJ, Ball KD, Bredesen DE. A novel motif identified in dependence receptors. PLoS One 2007; 2: e463.
39. Blits-Huizinga CT, Nelersa CM, Malhotra A, Liebl DJ. Ephrins and their receptors: binding versus biology. IUBMB Life 2004; 56: 257-265.
40. Ji XD, Li G, Feng YX, Zhao JS, Li JJ, Sun ZJ et al. EphB3 is overexpressed in non-smallcell lung cancer and promotes tumor metastasis by enhancing cell survival and migration. Cancer Res 2011; 71: 1156-1166.
41. Li G, Ji XD, Gao H, Zhao JS, Xu JF, Sun ZJ et al. EphB3 suppresses non-small-cell lung cancer metastasis via a PP2A/RACK1/Akt signalling complex. Nat Commun 2012; 3: 667.
42. Guicciardi ME, Gores GJ. Life and death by death receptors. FASEB J 2009; 23: 1625-1637.
43. Cowan CA, Yokoyama N, Bianchi LM, Henkemeyer M, Fritzsch B. EphB2 guides axons at the midline and is necessary for normal vestibular function. Neuron 2000; 26: 417-430.
44. Henkemeyer M, Orioli D, Henderson JT, Saxton TM, Roder J, Pawson T et al. Nuk controls pathfinding of commissural axons in the mammalian central nervous system. Cell 1996; 86: 35-46.
45. Orioli D, Henkemeyer M, Lemke G, Klein R, Pawson T. Sek4 and Nuk receptors cooperate in guidance of commissural axons and in palate formation. EMBO J 1996; 15: 6035-6049.
46. Yokoyama N, Romero MI, Cowan CA, Galvan P, Helmbacher F, Charnay P et al. Forward signaling mediated by ephrin-B3 prevents contralateral corticospinal axons from recrossing the spinal cord midline. Neuron 2001; 29: 85-97.